Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling
Purpose: As genetic counseling and testing become more fully integrated into clinical care, alternative delivery models are increasingly prominent. This study examines predictors of genetic testing for hereditary breast/ovarian cancer among high-risk women in a randomized trial of in-person versus t...
Saved in:
Published in | Genetics in medicine Vol. 17; no. 6; pp. 467 - 475 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Nature Publishing Group US
01.06.2015
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Purpose:
As genetic counseling and testing become more fully integrated into clinical care, alternative delivery models are increasingly prominent. This study examines predictors of genetic testing for hereditary breast/ovarian cancer among high-risk women in a randomized trial of in-person versus telephone-based genetic counseling.
Methods:
Methods include multivariable logistic regression and interaction analyses.
Results:
Of the 669 participants, 600 completed counseling and 523 received test results. As previously reported, participants randomized to telephone counseling were significantly less likely to be tested. In intention-to-treat analyses, completion of counseling and testing was associated with: race/ethnicity (odds ratio (OR) = 1.96, 95% confidence interval (CI): 1.20–3.20), perceived stress (OR = 0.89, 95% CI: 0.81–0.98), knowledge (OR = 1.12, 95% CI: 1.02–1.23), and randomization group (OR = 1.48, 95% CI: 1.01–2.16). Further, race/ethnicity moderated the association between randomization group and testing; minority women receiving telephone counseling were least likely to complete testing.
Conclusion:
Evidence for logistical and communication-based explanations for this interaction is presented. The overall increased access made possible with telephone genetic counseling should be considered in light of the possibility that this may also lead to lower rates of testing among high-risk minority women. Additional care should be taken to assess and address potential barriers when services are delivered by telephone.
Genet Med
17
6, 467–475. |
---|---|
AbstractList | As genetic counseling and testing become more fully integrated into clinical care, alternative delivery models are increasingly prominent. This study examines predictors of genetic testing for hereditary breast/ovarian cancer among high-risk women in a randomized trial of in-person versus telephone-based genetic counseling.PURPOSEAs genetic counseling and testing become more fully integrated into clinical care, alternative delivery models are increasingly prominent. This study examines predictors of genetic testing for hereditary breast/ovarian cancer among high-risk women in a randomized trial of in-person versus telephone-based genetic counseling.Methods include multivariable logistic regression and interaction analyses.METHODSMethods include multivariable logistic regression and interaction analyses.Of the 669 participants, 600 completed counseling and 523 received test results. As previously reported, participants randomized to telephone counseling were significantly less likely to be tested. In intention-to-treat analyses, completion of counseling and testing was associated with: race/ethnicity (odds ratio (OR) = 1.96, 95% confidence interval (CI): 1.20-3.20), perceived stress (OR = 0.89, 95% CI: 0.81-0.98), knowledge (OR = 1.12, 95% CI: 1.02-1.23), and randomization group (OR = 1.48, 95% CI: 1.01-2.16). Further, race/ethnicity moderated the association between randomization group and testing; minority women receiving telephone counseling were least likely to complete testing.RESULTSOf the 669 participants, 600 completed counseling and 523 received test results. As previously reported, participants randomized to telephone counseling were significantly less likely to be tested. In intention-to-treat analyses, completion of counseling and testing was associated with: race/ethnicity (odds ratio (OR) = 1.96, 95% confidence interval (CI): 1.20-3.20), perceived stress (OR = 0.89, 95% CI: 0.81-0.98), knowledge (OR = 1.12, 95% CI: 1.02-1.23), and randomization group (OR = 1.48, 95% CI: 1.01-2.16). Further, race/ethnicity moderated the association between randomization group and testing; minority women receiving telephone counseling were least likely to complete testing.Evidence for logistical and communication-based explanations for this interaction is presented. The overall increased access made possible with telephone genetic counseling should be considered in light of the possibility that this may also lead to lower rates of testing among high-risk minority women. Additional care should be taken to assess and address potential barriers when services are delivered by telephone.Genet Med 17 6, 467-475.CONCLUSIONEvidence for logistical and communication-based explanations for this interaction is presented. The overall increased access made possible with telephone genetic counseling should be considered in light of the possibility that this may also lead to lower rates of testing among high-risk minority women. Additional care should be taken to assess and address potential barriers when services are delivered by telephone.Genet Med 17 6, 467-475. As genetic counseling and testing become more fully integrated into clinical care, alternative delivery models are increasingly prominent. This study examines predictors of genetic testing for hereditary breast/ovarian cancer among high-risk women in a randomized trial of in-person versus telephone-based genetic counseling. Methods include multivariable logistic regression and interaction analyses. Of the 669 participants, 600 completed counseling and 523 received test results. As previously reported, participants randomized to telephone counseling were significantly less likely to be tested. In intention-to-treat analyses, completion of counseling and testing was associated with: race/ethnicity (odds ratio (OR) = 1.96, 95% confidence interval (CI): 1.20-3.20), perceived stress (OR = 0.89, 95% CI: 0.81-0.98), knowledge (OR = 1.12, 95% CI: 1.02-1.23), and randomization group (OR = 1.48, 95% CI: 1.01-2.16). Further, race/ethnicity moderated the association between randomization group and testing; minority women receiving telephone counseling were least likely to complete testing. Evidence for logistical and communication-based explanations for this interaction is presented. The overall increased access made possible with telephone genetic counseling should be considered in light of the possibility that this may also lead to lower rates of testing among high-risk minority women. Additional care should be taken to assess and address potential barriers when services are delivered by telephone.Genet Med 17 6, 467-475. Purpose: As genetic counseling and testing become more fully integrated into clinical care, alternative delivery models are increasingly prominent. This study examines predictors of genetic testing for hereditary breast/ovarian cancer among high-risk women in a randomized trial of in-person versus telephone-based genetic counseling. Methods: Methods include multivariable logistic regression and interaction analyses. Results: Of the 669 participants, 600 completed counseling and 523 received test results. As previously reported, participants randomized to telephone counseling were significantly less likely to be tested. In intention-to-treat analyses, completion of counseling and testing was associated with: race/ethnicity (odds ratio (OR) = 1.96, 95% confidence interval (CI): 1.20-3.20), perceived stress (OR = 0.89, 95% CI: 0.81-0.98), knowledge (OR = 1.12, 95% CI: 1.02-1.23), and randomization group (OR = 1.48, 95% CI: 1.01-2.16). Further, race/ ethnicity moderated the association between randomization group and testing; minority women receiving telephone counseling were least likely to complete testing. Conclusion: Evidence for logistical and communication-based explanations for this interaction is presented. The overall increased access made possible with telephone genetic counseling should be considered in light of the possibility that this may also lead to lower rates of testing among high-risk minority women. Additional care should be taken to assess and address potential barriers when services are delivered by telephone. Purpose:As genetic counseling and testing become more fully integrated into clinical care, alternative delivery models are increasingly prominent. This study examines predictors of genetic testing for hereditary breast/ovarian cancer among high-risk women in a randomized trial of in-person versus telephone-based genetic counseling.Methods:Methods include multivariable logistic regression and interaction analyses.Results:Of the 669 participants, 600 completed counseling and 523 received test results. As previously reported, participants randomized to telephone counseling were significantly less likely to be tested. In intention-to-treat analyses, completion of counseling and testing was associated with: race/ethnicity (odds ratio (OR) = 1.96, 95% confidence interval (CI): 1.20-3.20), perceived stress (OR = 0.89, 95% CI: 0.81-0.98), knowledge (OR = 1.12, 95% CI: 1.02-1.23), and randomization group (OR = 1.48, 95% CI: 1.01-2.16). Further, race/ethnicity moderated the association between randomization group and testing; minority women receiving telephone counseling were least likely to complete testing.Conclusion:Evidence for logistical and communication-based explanations for this interaction is presented. The overall increased access made possible with telephone genetic counseling should be considered in light of the possibility that this may also lead to lower rates of testing among high-risk minority women. Additional care should be taken to assess and address potential barriers when services are delivered by telephone.Genet Med 17 6, 467-475. Purpose: As genetic counseling and testing become more fully integrated into clinical care, alternative delivery models are increasingly prominent. This study examines predictors of genetic testing for hereditary breast/ovarian cancer among high-risk women in a randomized trial of in-person versus telephone-based genetic counseling. Methods: Methods include multivariable logistic regression and interaction analyses. Results: Of the 669 participants, 600 completed counseling and 523 received test results. As previously reported, participants randomized to telephone counseling were significantly less likely to be tested. In intention-to-treat analyses, completion of counseling and testing was associated with: race/ethnicity (odds ratio (OR) = 1.96, 95% confidence interval (CI): 1.20–3.20), perceived stress (OR = 0.89, 95% CI: 0.81–0.98), knowledge (OR = 1.12, 95% CI: 1.02–1.23), and randomization group (OR = 1.48, 95% CI: 1.01–2.16). Further, race/ethnicity moderated the association between randomization group and testing; minority women receiving telephone counseling were least likely to complete testing. Conclusion: Evidence for logistical and communication-based explanations for this interaction is presented. The overall increased access made possible with telephone genetic counseling should be considered in light of the possibility that this may also lead to lower rates of testing among high-risk minority women. Additional care should be taken to assess and address potential barriers when services are delivered by telephone. Genet Med 17 6, 467–475. |
Author | Peshkin, Beth N. McKinnon, Wendy Hooker, Gillian W. Garber, Judy Schwartz, Marc D. Valdimarsdottir, Heiddis B. Nusbaum, Rachel Isaacs, Claudine Kelly, Scott Butrick, Morgan Feeley, Lisa Graves, Kristi Wood, Marie Jandorf, Lina Luta, George DeMarco, Tiffani McCormick, Shelley R. |
Author_xml | – sequence: 1 givenname: Morgan surname: Butrick fullname: Butrick, Morgan organization: Laboratory of Immunology, National Institute of Allergy and Infectious Disease, National Institutes of Health – sequence: 2 givenname: Scott orcidid: 0000-0002-0375-1040 surname: Kelly fullname: Kelly, Scott organization: Department of Oncology, Cancer Prevention and Control Program and Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University – sequence: 3 givenname: Beth N. surname: Peshkin fullname: Peshkin, Beth N. organization: Department of Oncology, Cancer Prevention and Control Program and Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University – sequence: 4 givenname: George surname: Luta fullname: Luta, George organization: Department of Biostatistics, Bioinformatics, and Biomathematics, Lombardi Comprehensive Cancer Center, Georgetown University – sequence: 5 givenname: Rachel surname: Nusbaum fullname: Nusbaum, Rachel organization: Department of Oncology, Cancer Prevention and Control Program and Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University – sequence: 6 givenname: Gillian W. surname: Hooker fullname: Hooker, Gillian W. organization: Social and Behavioral Research Branch, National Human Genome Research Institute, National Institutes of Health – sequence: 7 givenname: Kristi surname: Graves fullname: Graves, Kristi organization: Department of Oncology, Cancer Prevention and Control Program and Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University – sequence: 8 givenname: Lisa surname: Feeley fullname: Feeley, Lisa organization: Department of Oncology, Cancer Prevention and Control Program and Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University – sequence: 9 givenname: Claudine surname: Isaacs fullname: Isaacs, Claudine organization: Department of Oncology, Cancer Prevention and Control Program and Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University – sequence: 10 givenname: Heiddis B. surname: Valdimarsdottir fullname: Valdimarsdottir, Heiddis B. organization: Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai – sequence: 11 givenname: Lina surname: Jandorf fullname: Jandorf, Lina organization: Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai – sequence: 12 givenname: Tiffani surname: DeMarco fullname: DeMarco, Tiffani organization: Department of Oncology, Cancer Prevention and Control Program and Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University – sequence: 13 givenname: Marie surname: Wood fullname: Wood, Marie organization: Familial Cancer Program of the Vermont Cancer Center, University of Vermont College of Medicine – sequence: 14 givenname: Wendy surname: McKinnon fullname: McKinnon, Wendy organization: Familial Cancer Program of the Vermont Cancer Center, University of Vermont College of Medicine – sequence: 15 givenname: Judy surname: Garber fullname: Garber, Judy organization: Center for Cancer Genetics and Prevention, Dana Farber Cancer Institute, Harvard Medical School – sequence: 16 givenname: Shelley R. surname: McCormick fullname: McCormick, Shelley R. organization: Center for Cancer Genetics and Prevention, Dana Farber Cancer Institute, Harvard Medical School – sequence: 17 givenname: Marc D. surname: Schwartz fullname: Schwartz, Marc D. email: schwartm@georgetown.edu organization: Department of Oncology, Cancer Prevention and Control Program and Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25232856$$D View this record in MEDLINE/PubMed |
BookMark | eNqF0cuLFDEQB-AgK-5Db54l4MWDPZuk8zyu4xMWBNmzIZ2uGbN2J22SPuhfb4ZZRRbFU-rwVfFL1Tk6iSkCQk8p2VDS68t9mDeMUL6hTDxAZ1T0pCO9lCetJkZ3vSTkFJ2XcksIVT0jj9ApE6xnWsgz9Pl1KIvLoQYoOES8LtV9BZx2-NWn7RW9ZHgPEWrwuEKpIe4PyOHs4pjm8ANGXHNw06GhwgTLlxYO-7TGAlPTj9HDnZsKPLl7L9DN2zc32_fd9cd3H7ZX153nTNdOaS_MoAxzeuRGEyBKee1GOdBRGy0GbqQ0zrCdlryXSriBei_VQLViDPoL9OI4dsnp29qC2jkUD9PkIqS1WKracoSUhP-fSi2JFJrrRp_fo7dpzbH9w1LNuaKCC9PUszu1DjOMdslhdvm7_bXjBl4egc-plAy734QSezihbSe0hxPalrJxdo_7UF0NKdbswvSvpu7YVNrsuIf8R9S_-Z-0Dqr5 |
CitedBy_id | crossref_primary_10_1089_gtmb_2020_29058_sjt crossref_primary_10_1002_jgc4_1174 crossref_primary_10_1038_s41431_020_00783_9 crossref_primary_10_1007_s12687_017_0350_4 crossref_primary_10_1016_j_gim_2022_03_002 crossref_primary_10_1002_ajmg_c_31866 crossref_primary_10_1016_j_healthpol_2021_04_010 crossref_primary_10_1158_1055_9965_EPI_17_0389 crossref_primary_10_1016_j_gim_2022_02_004 crossref_primary_10_1002_jgc4_1773 crossref_primary_10_1007_s12687_021_00530_7 crossref_primary_10_1186_s12913_021_06489_y crossref_primary_10_1007_s12687_019_00413_y crossref_primary_10_1016_j_soc_2015_06_001 crossref_primary_10_3389_fpubh_2022_984926 crossref_primary_10_1016_j_cct_2023_107309 crossref_primary_10_3390_cancers10110435 crossref_primary_10_1093_jncimonographs_lgae004 crossref_primary_10_1002_cam4_3968 crossref_primary_10_1002_jgc4_1343 crossref_primary_10_1002_pd_6297 crossref_primary_10_1002_jgc4_1341 crossref_primary_10_1097_MLR_0000000000001405 crossref_primary_10_1002_jgc4_1424 crossref_primary_10_1007_s13187_019_01599_y crossref_primary_10_1002_jgc4_1465 crossref_primary_10_1002_jgc4_1469 crossref_primary_10_1159_000503129 crossref_primary_10_1002_jgc4_1628 crossref_primary_10_3389_fdgth_2022_961128 crossref_primary_10_1002_cncr_35116 crossref_primary_10_1089_gtmb_2018_0253 crossref_primary_10_1016_j_ejca_2017_03_014 crossref_primary_10_1186_s13073_019_0691_1 crossref_primary_10_1200_EDBK_238937 crossref_primary_10_1002_cncr_34053 crossref_primary_10_1038_s41431_019_0390_9 crossref_primary_10_1177_1357633X211052220 crossref_primary_10_1007_s10897_017_0089_4 crossref_primary_10_1007_s12687_018_0379_z crossref_primary_10_1007_s10897_016_9986_1 crossref_primary_10_1002_jgc4_1193 crossref_primary_10_1002_jgc4_1078 crossref_primary_10_1002_jgc4_1792 crossref_primary_10_1007_s10897_017_0082_y crossref_primary_10_1002_jgc4_1230 crossref_primary_10_1002_jgc4_1351 crossref_primary_10_1093_tbm_ibac106 crossref_primary_10_1001_jamanetworkopen_2024_45363 crossref_primary_10_5301_tj_5000407 crossref_primary_10_1089_jwh_2019_7984 crossref_primary_10_2217_pme_15_39 crossref_primary_10_1016_j_clon_2018_04_004 crossref_primary_10_1038_s44276_023_00009_7 crossref_primary_10_1111_hiv_13701 crossref_primary_10_1080_03630242_2023_2237610 crossref_primary_10_1007_s12687_017_0347_z crossref_primary_10_3390_curroncol28050301 crossref_primary_10_1007_s10549_018_4773_3 crossref_primary_10_1007_s10897_015_9848_2 crossref_primary_10_1007_s40615_018_00556_7 crossref_primary_10_1016_j_ejmg_2018_12_004 crossref_primary_10_1016_j_outlook_2019_06_004 crossref_primary_10_1136_ijgc_2019_001168 crossref_primary_10_1200_JCO_19_02010 crossref_primary_10_3389_fgene_2023_1239817 crossref_primary_10_1002_jgc4_1481 crossref_primary_10_1002_jgc4_1365 crossref_primary_10_1007_s10549_019_05515_2 crossref_primary_10_1007_s10689_016_9900_x crossref_primary_10_1002_jgc4_1324 crossref_primary_10_1002_hast_1016 crossref_primary_10_1159_000489117 crossref_primary_10_1002_jgc4_1723 crossref_primary_10_1016_j_pec_2023_107648 crossref_primary_10_1080_09581596_2016_1179263 crossref_primary_10_1188_18_ONF_96_105 crossref_primary_10_3390_ijerph16203899 crossref_primary_10_1016_j_ctrv_2024_102695 crossref_primary_10_1093_jncics_pkx002 crossref_primary_10_1093_tbm_ibx051 crossref_primary_10_1007_s10897_015_9897_6 crossref_primary_10_1007_s10897_015_9899_4 |
ContentType | Journal Article |
Copyright | The Author(s) 2015 Copyright Nature Publishing Group Jun 2015 |
Copyright_xml | – notice: The Author(s) 2015 – notice: Copyright Nature Publishing Group Jun 2015 |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 8FD FR3 P64 RC3 |
DOI | 10.1038/gim.2014.125 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts Genetics Abstracts |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic Genetics Abstracts Engineering Research Database Technology Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitleList | MEDLINE - Academic MEDLINE Genetics Abstracts ProQuest One Academic Middle East (New) |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1530-0366 |
EndPage | 475 |
ExternalDocumentID | 4265482571 25232856 10_1038_gim_2014_125 |
Genre | Multicenter Study Randomized Controlled Trial Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: R01 CA108933 – fundername: NCI NIH HHS grantid: P30 CA051008 – fundername: Intramural NIH HHS grantid: Z99 AI999999 |
GroupedDBID | --- .-D ..I .GJ 08G 39C 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 70F 7X7 88E 8FI 8FJ AAFWJ AAKAS AALRI AAXUO AAYEP AAYWO ABAWZ ABJNI ABLJU ABUWG ACGFO ACGFS ACKTT ACRQY ACVFH ADBBV ADBIZ ADCNI ADVLN ADZCM AE3 AEJRE AENEX AEUPX AEXYK AFETI AFJKZ AFKRA AFPUW AFSHS AFTRI AGAYW AGCQF AHMBA AHSBF AHVBC AIGII AILAN AITUG AIZYK AJRNO AKBMS AKRWK AKYEP ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP AXYYD BENPR BKKNO BPHCQ BS7 BVXVI C6C CCPQU CS3 DNIVK DU5 EBS EE. EFKBS EIOEI EJD EX3 F5P FDB FDQFY FERAY FIZPM FSGXE FYUFA H0~ HMCUK JF9 JG8 JK3 JSO K-O KD2 M1P M41 N9A NQJWS N~M OAG OAH ODA OK1 OLG OVD OWU OWV OWW OWX OWY OWZ P-K P2P PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO R58 RNT RNTTT ROL S4R SNYQT SOHCF SOJ SRMVM SWTZT T8P TAOOD TBHMF TDRGL TEORI TSG UKHRP VVN W3M WOQ WOW XXN XYM YFH ZFV AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 8FD FR3 P64 RC3 |
ID | FETCH-LOGICAL-c428t-78c59b792a8d4980e077c8ad6b1d8985b49669a92f8643675ab1cc67b18722e3 |
IEDL.DBID | 7X7 |
ISSN | 1098-3600 1530-0366 |
IngestDate | Fri Jul 11 10:18:46 EDT 2025 Fri Jul 11 15:04:17 EDT 2025 Fri Jul 25 07:27:47 EDT 2025 Mon Jul 21 06:02:55 EDT 2025 Tue Jul 01 02:59:06 EDT 2025 Thu Apr 24 22:59:11 EDT 2025 Mon Jul 21 06:06:54 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | genetic counseling psychosocial predictors cancer genetic testing telephone counseling |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c428t-78c59b792a8d4980e077c8ad6b1d8985b49669a92f8643675ab1cc67b18722e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
ORCID | 0000-0002-0375-1040 0000000203751040 |
OpenAccessLink | https://www.nature.com/articles/gim.2014.125 |
PMID | 25232856 |
PQID | 1844715459 |
PQPubID | 2043492 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_1712556604 proquest_miscellaneous_1686065848 proquest_journals_1844715459 pubmed_primary_25232856 crossref_primary_10_1038_gim_2014_125 crossref_citationtrail_10_1038_gim_2014_125 springer_journals_10_1038_gim_2014_125 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-06-01 |
PublicationDateYYYYMMDD | 2015-06-01 |
PublicationDate_xml | – month: 06 year: 2015 text: 2015-06-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: United States – name: Bethesda |
PublicationSubtitle | Official journal of the American College of Medical Genetics and Genomics |
PublicationTitle | Genetics in medicine |
PublicationTitleAbbrev | Genet Med |
PublicationTitleAlternate | Genet Med |
PublicationYear | 2015 |
Publisher | Nature Publishing Group US Elsevier Limited |
Publisher_xml | – name: Nature Publishing Group US – name: Elsevier Limited |
References | VigHSWangCThe evolution of personalized cancer genetic counseling in the era of personalized medicineFam Cancer20121153954410.1007/s10689-012-9524-8 LevyDEByfieldSDComstockCBUnderutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at riskGenet Med20111334935510.1097/GIM.0b013e3182091ba4 HoskinsLMWerner-LinAA multi-case report of the pathways to and through genetic testing and cancer risk management for BRCA mutation-positive women aged 18-25J Genet Couns201322273810.1007/s10897-012-9521-y BusijaLPausenbergerEHainesTPHaymesSBuchbinderROsborneRHAdult measures of general health and health-related quality of life: Medical Outcomes Study Short Form 36-Item (SF-36) and Short Form 12-Item (SF-12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF-6D), Health Utilities Index Mark 3 (HUI3), Quality of Well-Being Scale (QWB), and Assessment of Quality of Life (AQoL)Arthritis Care Res (Hoboken)201163suppl 11S383S41210.1002/acr.20541 HoskinsLMGreeneMHAnticipatory loss and early mastectomy for young female BRCA1/2 mutation carriersQual Health Res2012221633164610.1177/1049732312458182 StreetRLJrO’MalleyKJCooperLAHaidetPUnderstanding concordance in patient-physician relationships: personal and ethnic dimensions of shared identityAnn Fam Med2008619820510.1370/afm.821 US Preventive Services Task Force. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Draft Recommendation Statement. April 2013. AHRQ Publication No. 12-05164-EF-2. http://www.uspreventiveservicestaskforce.org/uspstf12/brcatest/draftrecbrcatest.htm. BaumanisLEvansJPCallananNSussweinLRTelephoned BRCA1/2 genetic test results: prevalence, practice, and patient satisfactionJ Genet Couns2009184474631:STN:280:DC%2BD1MnmtlyntQ%3D%3D10.1007/s10897-009-9238-8 ErblichJBrownKKimYValdimarsdottirHBLivingstonBEBovbjergDHDevelopment and validation of a Breast Cancer Genetic Counseling Knowledge QuestionnairePatient Educ Couns20055618219110.1016/j.pec.2004.02.007 National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian. V.1.2014. http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf. McKinstryBHammersleyVBurtonCThe quality, safety and content of telephone and face-to-face consultations: a comparative studyQual Saf Health Care2010192983031:STN:280:DC%2BC3cjjtVWmtA%3D%3D10.1136/qshc.2008.027763 BrierleyKLBlouchECogswellWAdverse events in cancer genetic testing: medical, ethical, legal, and financial implicationsCancer J20121830330910.1097/PPO.0b013e3182609490 McKinstryBSheikhAUnresolved questions in telephone consultingJ R Soc Med2006992310.1258/jrsm.99.1.2 O’ConnorAMValidation of a decisional conflict scaleMed Decis Making199515253010.1177/0272989X9501500105 FormanADHallMJInfluence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancerBreast J200915suppl 1S56S6210.1111/j.1524-4741.2009.00798.x CohenSKamarckTMermelsteinRA global measure of perceived stressJ Health Soc Behav1983243853961:STN:280:DyaL2c7js12iug%3D%3D10.2307/2136404 GravesKDChristopherJHarrisonTMPeshkinBNIsaacsCSheppardVBProviders’ perceptions and practices regarding BRCA1/2 genetic counseling and testing in African American womenJ Genet Couns20112067468910.1007/s10897-011-9396-3 BealACChouSCPalmerRHTestaMANewmanCEzhuthachanSThe changing face of race: risk factors for neonatal hyperbilirubinemiaPediatrics20061171618162510.1542/peds.2005-1203 BradburyARPatrick-MillerLFetzerDGenetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test resultsClin Genet2011791251311:STN:280:DC%2BC3M%2FpsVamtw%3D%3D10.1111/j.1399-0004.2010.01540.x MackenzieAPatrick-MillerLBradburyARControversies in communication of genetic risk for hereditary breast cancerBreast J200915suppl 1S25S3210.1111/j.1524-4741.2009.00800.x CukierYRThompsonHSSussnerKFactors associated with psychological distress among women of African descent at high risk for BRCA mutationsJ Genet Couns20132210110710.1007/s10897-012-9510-1 WhamDVuTChan-SmutkoGKobelkaCUrbauerDHealdBAssessment of clinical practices among cancer genetic counselorsFam Cancer2010945946810.1007/s10689-010-9326-9 GordonHSStreetRLJrSharfBFSouchekJRacial differences in doctors’ information-giving and patients’ participationCancer20061071313132010.1002/cncr.22122 DougallALSmithAWSomersTJPoslusznyDMRubinsteinWSBaumACoping with genetic testing for breast cancer susceptibilityPsychosom Med200971981051:CAS:528:DC%2BD1MXitlajtg%3D%3D10.1097/PSY.0b013e318190d7b4 HelmesAWCulverJOBowenDJResults of a randomized study of telephone versus in-person breast cancer risk counselingPatient Educ Couns2006649610310.1016/j.pec.2005.12.002 Kinney AY, Butler KM, Boucher KM, et al. Telephone vs. in-person genetic counseling for hereditary breast and ovarian cancer in urban and rural women: a cluster randomized trial. J Natl Cancer Inst, in press. HorowitzMWilnerNAlvarezWImpact of Event Scale: a measure of subjective stressPsychosom Med1979412092181:STN:280:DyaE1M3kslGjug%3D%3D10.1097/00006842-197905000-00004 ThorntonRLPoweNRRoterDCooperLAPatient-physician social concordance, medical visit communication and patients’ perceptions of health care qualityPatient Educ Couns201185e201e20810.1016/j.pec.2011.07.015 National Society of Genetic Counselors. 2012 Professional Status Survey: Executive Summary. http://nsgc.org/p/cm/ld/fid=68. AghaZRoterDLSchapiraRMAn evaluation of patient-physician communication style during telemedicine consultationsJ Med Internet Res200911e3610.2196/jmir.1193 BerryDAIversenESJrGudbjartssonDFBRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genesJ Clin Oncol200220270127121:CAS:528:DC%2BD38XkvF2mtrs%3D10.1200/JCO.2002.05.121 CohenSAMarvinMLRileyBDVigHSRousseauJAGustafsonSLIdentification of genetic counseling service delivery models in practice: a report from the NSGC Service Delivery Model Task ForceJ Genet Couns20132241142110.1007/s10897-013-9588-0 SmedleyBDStithAYNelsonARUnequal Treatment: Confronting Racial and Ethnic Disparities in Health Care.2003National Academies Press SchwartzMDValdimarsdottirHBPeshkinBNRandomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancerJ Clin Oncol20143261862610.1200/JCO.2013.51.3226 PeshkinBNDemarcoTAGravesKDTelephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trialGenet Test200812375210.1089/gte.2006.0525 ArmstrongKMiccoECarneyAStopferJPuttMRacial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancerJAMA2005293172917361:CAS:528:DC%2BD2MXjtlWmtLc%3D10.1001/jama.293.14.1729 LipkusIMKleinWMRimerBKCommunicating breast cancer risks to women using different formatsCancer Epidemiol Biomarkers Prev2001108958981:STN:280:DC%2BD3MvktlahtQ%3D%3D11489757 CooperLARoterDLJohnsonRLFordDESteinwachsDMPoweNRPatient-centered communication, ratings of care, and concordance of patient and physician raceAnn Intern Med200313990791510.7326/0003-4819-139-11-200312020-00009 JohnsonRLRoterDPoweNRCooperLAPatient race/ethnicity and quality of patient-physician communication during medical visitsAm J Public Health2004942084209010.2105/AJPH.94.12.2084 WareJJrKosinskiMKellerSDA 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validityMed Care19963422023310.1097/00005650-199603000-00003 Street (10.1038/gim.2014.125_bb0190) Cukier (10.1038/gim.2014.125_bb0165) Levy (10.1038/gim.2014.125_bb0155) Agha (10.1038/gim.2014.125_bb0200) Busija (10.1038/gim.2014.125_bb0130) Helmes (10.1038/gim.2014.125_bb0065) Lipkus (10.1038/gim.2014.125_bb0105) Peshkin (10.1038/gim.2014.125_bb0090) Thornton (10.1038/gim.2014.125_bb0195) Dougall (10.1038/gim.2014.125_bb0135) Cooper (10.1038/gim.2014.125_bb0170) 10.1038/gim.2014.125_bb0010 Baumanis (10.1038/gim.2014.125_bb0035) 10.1038/gim.2014.125_bb0015 Berry (10.1038/gim.2014.125_bb0095) Hoskins (10.1038/gim.2014.125_bb0145) Horowitz (10.1038/gim.2014.125_bb0115) Bradbury (10.1038/gim.2014.125_bb0040) 10.1038/gim.2014.125_bb0075 Vig (10.1038/gim.2014.125_bb0030) Graves (10.1038/gim.2014.125_bb0150) Cohen (10.1038/gim.2014.125_bb0120) Johnson (10.1038/gim.2014.125_bb0180) Armstrong (10.1038/gim.2014.125_bb0080) Wham (10.1038/gim.2014.125_bb0045) McKinstry (10.1038/gim.2014.125_bb0060) Cohen (10.1038/gim.2014.125_bb0205) Erblich (10.1038/gim.2014.125_bb0100) McKinstry (10.1038/gim.2014.125_bb0055) Forman (10.1038/gim.2014.125_bb0085) Ware (10.1038/gim.2014.125_bb0125) Gordon (10.1038/gim.2014.125_bb0175) Brierley (10.1038/gim.2014.125_bb0025) Hoskins (10.1038/gim.2014.125_bb0140) Beal (10.1038/gim.2014.125_bb0160) Smedley (10.1038/gim.2014.125_bb0185) 2003 10.1038/gim.2014.125_bb0020 Mackenzie (10.1038/gim.2014.125_bb0070) O’Connor (10.1038/gim.2014.125_bb0110) Schwartz (10.1038/gim.2014.125_bb0050) |
References_xml | – reference: BerryDAIversenESJrGudbjartssonDFBRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genesJ Clin Oncol200220270127121:CAS:528:DC%2BD38XkvF2mtrs%3D10.1200/JCO.2002.05.121 – reference: ErblichJBrownKKimYValdimarsdottirHBLivingstonBEBovbjergDHDevelopment and validation of a Breast Cancer Genetic Counseling Knowledge QuestionnairePatient Educ Couns20055618219110.1016/j.pec.2004.02.007 – reference: ThorntonRLPoweNRRoterDCooperLAPatient-physician social concordance, medical visit communication and patients’ perceptions of health care qualityPatient Educ Couns201185e201e20810.1016/j.pec.2011.07.015 – reference: CooperLARoterDLJohnsonRLFordDESteinwachsDMPoweNRPatient-centered communication, ratings of care, and concordance of patient and physician raceAnn Intern Med200313990791510.7326/0003-4819-139-11-200312020-00009 – reference: SchwartzMDValdimarsdottirHBPeshkinBNRandomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancerJ Clin Oncol20143261862610.1200/JCO.2013.51.3226 – reference: WareJJrKosinskiMKellerSDA 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validityMed Care19963422023310.1097/00005650-199603000-00003 – reference: HoskinsLMGreeneMHAnticipatory loss and early mastectomy for young female BRCA1/2 mutation carriersQual Health Res2012221633164610.1177/1049732312458182 – reference: StreetRLJrO’MalleyKJCooperLAHaidetPUnderstanding concordance in patient-physician relationships: personal and ethnic dimensions of shared identityAnn Fam Med2008619820510.1370/afm.821 – reference: BrierleyKLBlouchECogswellWAdverse events in cancer genetic testing: medical, ethical, legal, and financial implicationsCancer J20121830330910.1097/PPO.0b013e3182609490 – reference: PeshkinBNDemarcoTAGravesKDTelephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trialGenet Test200812375210.1089/gte.2006.0525 – reference: GravesKDChristopherJHarrisonTMPeshkinBNIsaacsCSheppardVBProviders’ perceptions and practices regarding BRCA1/2 genetic counseling and testing in African American womenJ Genet Couns20112067468910.1007/s10897-011-9396-3 – reference: SmedleyBDStithAYNelsonARUnequal Treatment: Confronting Racial and Ethnic Disparities in Health Care.2003National Academies Press – reference: LipkusIMKleinWMRimerBKCommunicating breast cancer risks to women using different formatsCancer Epidemiol Biomarkers Prev2001108958981:STN:280:DC%2BD3MvktlahtQ%3D%3D11489757 – reference: JohnsonRLRoterDPoweNRCooperLAPatient race/ethnicity and quality of patient-physician communication during medical visitsAm J Public Health2004942084209010.2105/AJPH.94.12.2084 – reference: McKinstryBHammersleyVBurtonCThe quality, safety and content of telephone and face-to-face consultations: a comparative studyQual Saf Health Care2010192983031:STN:280:DC%2BC3cjjtVWmtA%3D%3D10.1136/qshc.2008.027763 – reference: MackenzieAPatrick-MillerLBradburyARControversies in communication of genetic risk for hereditary breast cancerBreast J200915suppl 1S25S3210.1111/j.1524-4741.2009.00800.x – reference: National Society of Genetic Counselors. 2012 Professional Status Survey: Executive Summary. http://nsgc.org/p/cm/ld/fid=68. – reference: Kinney AY, Butler KM, Boucher KM, et al. Telephone vs. in-person genetic counseling for hereditary breast and ovarian cancer in urban and rural women: a cluster randomized trial. J Natl Cancer Inst, in press. – reference: ArmstrongKMiccoECarneyAStopferJPuttMRacial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancerJAMA2005293172917361:CAS:528:DC%2BD2MXjtlWmtLc%3D10.1001/jama.293.14.1729 – reference: LevyDEByfieldSDComstockCBUnderutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at riskGenet Med20111334935510.1097/GIM.0b013e3182091ba4 – reference: DougallALSmithAWSomersTJPoslusznyDMRubinsteinWSBaumACoping with genetic testing for breast cancer susceptibilityPsychosom Med200971981051:CAS:528:DC%2BD1MXitlajtg%3D%3D10.1097/PSY.0b013e318190d7b4 – reference: FormanADHallMJInfluence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancerBreast J200915suppl 1S56S6210.1111/j.1524-4741.2009.00798.x – reference: WhamDVuTChan-SmutkoGKobelkaCUrbauerDHealdBAssessment of clinical practices among cancer genetic counselorsFam Cancer2010945946810.1007/s10689-010-9326-9 – reference: McKinstryBSheikhAUnresolved questions in telephone consultingJ R Soc Med2006992310.1258/jrsm.99.1.2 – reference: BradburyARPatrick-MillerLFetzerDGenetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test resultsClin Genet2011791251311:STN:280:DC%2BC3M%2FpsVamtw%3D%3D10.1111/j.1399-0004.2010.01540.x – reference: HelmesAWCulverJOBowenDJResults of a randomized study of telephone versus in-person breast cancer risk counselingPatient Educ Couns2006649610310.1016/j.pec.2005.12.002 – reference: National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian. V.1.2014. http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf. – reference: US Preventive Services Task Force. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Draft Recommendation Statement. April 2013. AHRQ Publication No. 12-05164-EF-2. http://www.uspreventiveservicestaskforce.org/uspstf12/brcatest/draftrecbrcatest.htm. – reference: VigHSWangCThe evolution of personalized cancer genetic counseling in the era of personalized medicineFam Cancer20121153954410.1007/s10689-012-9524-8 – reference: O’ConnorAMValidation of a decisional conflict scaleMed Decis Making199515253010.1177/0272989X9501500105 – reference: BealACChouSCPalmerRHTestaMANewmanCEzhuthachanSThe changing face of race: risk factors for neonatal hyperbilirubinemiaPediatrics20061171618162510.1542/peds.2005-1203 – reference: HorowitzMWilnerNAlvarezWImpact of Event Scale: a measure of subjective stressPsychosom Med1979412092181:STN:280:DyaE1M3kslGjug%3D%3D10.1097/00006842-197905000-00004 – reference: BusijaLPausenbergerEHainesTPHaymesSBuchbinderROsborneRHAdult measures of general health and health-related quality of life: Medical Outcomes Study Short Form 36-Item (SF-36) and Short Form 12-Item (SF-12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF-6D), Health Utilities Index Mark 3 (HUI3), Quality of Well-Being Scale (QWB), and Assessment of Quality of Life (AQoL)Arthritis Care Res (Hoboken)201163suppl 11S383S41210.1002/acr.20541 – reference: HoskinsLMWerner-LinAA multi-case report of the pathways to and through genetic testing and cancer risk management for BRCA mutation-positive women aged 18-25J Genet Couns201322273810.1007/s10897-012-9521-y – reference: CohenSAMarvinMLRileyBDVigHSRousseauJAGustafsonSLIdentification of genetic counseling service delivery models in practice: a report from the NSGC Service Delivery Model Task ForceJ Genet Couns20132241142110.1007/s10897-013-9588-0 – reference: AghaZRoterDLSchapiraRMAn evaluation of patient-physician communication style during telemedicine consultationsJ Med Internet Res200911e3610.2196/jmir.1193 – reference: BaumanisLEvansJPCallananNSussweinLRTelephoned BRCA1/2 genetic test results: prevalence, practice, and patient satisfactionJ Genet Couns2009184474631:STN:280:DC%2BD1MnmtlyntQ%3D%3D10.1007/s10897-009-9238-8 – reference: GordonHSStreetRLJrSharfBFSouchekJRacial differences in doctors’ information-giving and patients’ participationCancer20061071313132010.1002/cncr.22122 – reference: CohenSKamarckTMermelsteinRA global measure of perceived stressJ Health Soc Behav1983243853961:STN:280:DyaL2c7js12iug%3D%3D10.2307/2136404 – reference: CukierYRThompsonHSSussnerKFactors associated with psychological distress among women of African descent at high risk for BRCA mutationsJ Genet Couns20132210110710.1007/s10897-012-9510-1 – ident: 10.1038/gim.2014.125_bb0145 – ident: 10.1038/gim.2014.125_bb0010 – ident: 10.1038/gim.2014.125_bb0130 – ident: 10.1038/gim.2014.125_bb0085 – ident: 10.1038/gim.2014.125_bb0040 – ident: 10.1038/gim.2014.125_bb0150 – ident: 10.1038/gim.2014.125_bb0115 – ident: 10.1038/gim.2014.125_bb0060 – ident: 10.1038/gim.2014.125_bb0075 – ident: 10.1038/gim.2014.125_bb0125 – ident: 10.1038/gim.2014.125_bb0205 – ident: 10.1038/gim.2014.125_bb0025 – ident: 10.1038/gim.2014.125_bb0045 – ident: 10.1038/gim.2014.125_bb0120 – ident: 10.1038/gim.2014.125_bb0155 – ident: 10.1038/gim.2014.125_bb0055 – ident: 10.1038/gim.2014.125_bb0035 – ident: 10.1038/gim.2014.125_bb0175 – ident: 10.1038/gim.2014.125_bb0195 – ident: 10.1038/gim.2014.125_bb0140 – ident: 10.1038/gim.2014.125_bb0015 – ident: 10.1038/gim.2014.125_bb0110 – ident: 10.1038/gim.2014.125_bb0050 – ident: 10.1038/gim.2014.125_bb0095 – ident: 10.1038/gim.2014.125_bb0135 – ident: 10.1038/gim.2014.125_bb0170 – ident: 10.1038/gim.2014.125_bb0070 – ident: 10.1038/gim.2014.125_bb0030 – ident: 10.1038/gim.2014.125_bb0065 – ident: 10.1038/gim.2014.125_bb0105 – ident: 10.1038/gim.2014.125_bb0080 – year: 2003 ident: 10.1038/gim.2014.125_bb0185 – ident: 10.1038/gim.2014.125_bb0160 – ident: 10.1038/gim.2014.125_bb0200 – ident: 10.1038/gim.2014.125_bb0020 – ident: 10.1038/gim.2014.125_bb0100 – ident: 10.1038/gim.2014.125_bb0165 – ident: 10.1038/gim.2014.125_bb0180 – ident: 10.1038/gim.2014.125_bb0090 – ident: 10.1038/gim.2014.125_bb0190 |
SSID | ssj0017320 |
Score | 2.4198635 |
Snippet | Purpose:
As genetic counseling and testing become more fully integrated into clinical care, alternative delivery models are increasingly prominent. This study... As genetic counseling and testing become more fully integrated into clinical care, alternative delivery models are increasingly prominent. This study examines... Purpose:As genetic counseling and testing become more fully integrated into clinical care, alternative delivery models are increasingly prominent. This study... Purpose: As genetic counseling and testing become more fully integrated into clinical care, alternative delivery models are increasingly prominent. This study... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 467 |
SubjectTerms | 692/699/67/1347 692/699/67/1517/1709 692/700/139/1512 692/700/228/2050/1510 Adult Biomedicine Female Genes, BRCA1 Genes, BRCA2 Genetic Counseling Genetic Testing Healthcare Disparities Hereditary Breast and Ovarian Cancer Syndrome - diagnosis Hereditary Breast and Ovarian Cancer Syndrome - epidemiology Hereditary Breast and Ovarian Cancer Syndrome - genetics Human Genetics Humans Laboratory Medicine Middle Aged Odds Ratio original-research-article Risk Factors Telephone |
SummonAdditionalLinks | – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bS91AEB7UUvFFrPUSL2WFti8aTTbZ26OeVqSgD8WCTw17ixzUHNGcB_31zuaGopa-BTJLhtndfDPMzDcAXy1lmntbxtzmSZxLZ_HOaRFrrm2aOCY0Db3Dp2f85E_-64JdzMBe3wvTFO03lJbNb7qvDju4HIe28TTfR0CehQ-BtD2c5xEfDTkDkdGWe0DJOEMc78rck0y-WP0SgF55la8yog3QHC_BYuchksNWp08w46tl-NjOjHxYhvnTLhv-Gf7-GN-HIYKBE5WMKzK9rfWVJ5OSHP0eHaYHlODpCE2KpA5cGtVlENIE0clNbsaP3pFmZkdYUCP6hCp1T-zQpL4C58c_z0cncTcvIbYYRNSxkJYpIxTV0uVKJj4RwkrtuEmdVJKZHGMbpRUtJfohGClok1rLhUmloNRnqzBX4YfWgWTGp6VWiS5Vlpe-VMaZwNviGKOGMhvBbm_DwnZc4mGkxXXR5LQzWaDFi2DxAi0ewbdB-rbl0HhHbqvfjqK7SfcFRqCIn-jnqQh2htd4B0JiQ1d-MkUZLnnjSsl_yIg0sK3xJI9grd3qQRmK0TiVjEfwvd_7Zwq8oenG_wpuwgI-sra2bAvm6rup30YvpjZfmsP7BOv47Mw priority: 102 providerName: Springer Nature |
Title | Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling |
URI | https://link.springer.com/article/10.1038/gim.2014.125 https://www.ncbi.nlm.nih.gov/pubmed/25232856 https://www.proquest.com/docview/1844715459 https://www.proquest.com/docview/1686065848 https://www.proquest.com/docview/1712556604 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEB-0RfFFtH5Fa1lBfZHY7Cb79STt2VKEFikV7smwX5FDvTu93IP-9c4kuVio9jFkQoaZ3Z2ZnZnfALwMQjqVQpOrUBV5ZWLAPed07pQLvIhSO0G9w6dn6uRT9WEqp8OF22ooq9ycid1BHReB7sj3MRLBcxTtvX23_JHT1CjKrg4jNG7CNkGXUUmXno4BF9el6NEIrMlLtOxD4XtRYtA3ozZ0Xr3lNCT7skm64mdeyZF2puf4HtwdfEZ20Cv5PtxI8x241U-R_LUDt0-H_PgD-Px-tqKxgoSSymZztl627mtii4Ydnk8O-L5guF6obZG1hK4x_0JEjqG9iovvs98psm6KB33Qoj2iuvXEwti2_hAujo8uJif5MEEhDxhWtLk2QVqvrXAmVtYUqdA6GBeV59FYI32F0Y51VjQGPROMHZznISjtudFCpPIRbM3xR0-AlT7xxtnCNbasmtRYHz0huUQphRcyZPBmI8M6DOjiNOTiW91luUtTo8RrkniNEs_g1Ui97FE1_kO3u1FHPeytVf13JWTwYnyNu4JSHW6eFmukUUZ1zpW5hkZzwl9TRZXB417VIzMC43NhpMrg9Ub3lxj4B6dPr-f0GdxBStnXmO3CVvtznZ6jN9P6vW7J7sH24dHZx3N8mqjJHyo_83M |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3JbtNA9Km0YrkgKJuhwCBRLsjUHnu2A0JdldImQlWQesKazSgCnEAcofJP_CNvvIRKhd569hv76e3jtwG8tJRp7m0Zc5sncS6dRZ3TItZc2zRxTGgaeoeHIz74mL8_Zacr8LvvhQlllb1NbAy1m9rwj3wLbyJoR9Hfq3ez73HYGhWyq_0KjVYsjvzZT7yyzd8e7iF_Nyk92B_vDuJuq0BsMdSuYyEtU0YoqqXLlUx8IoSV2nGTOqkkMzneAJRWtJTorTGe1ia1lguTSkGpz_C112ANnyRoB9Z29kcfTpZpC5HRdvyBkjECJF2lfZLhLXMS-t7T_E0atnKf94EXAtsLSdnG1x3cgdtdkEq2W6m6Cyu-Wofr7drKs3W4MewS8vfg095kHvYYhrGsZFKRxazWXzyZlmTnZHc73aIEBTT0SZI6jPOoPgcgTdBBuum3yS_vSLM2JByo0QGGQnlP7LJP_j6Mr4K4D2C1wg89ApIZn5ZaJbpUWV76UhlnwugYxxg1lNkIXvc0LGw3zjxs1fhaNGn1TBZI8SJQvECKR7C5hJ61Yzz-A7fRs6PolHle_BW9CF4sH6MahtyKrvx0gTBc8iaak5fAiDQMfONJHsHDltVLZCjD0FYyHsGrnvfnEPgHpo8vx_Q53ByMh8fF8eHo6AncwlOsLXDbgNX6x8I_xVCqNs86ASZQXLHK_AH7pS0u |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQwcFSKqLggKK9AASNRLihs7MSvA0Kly6qltEKoSHtq5NgOWgHZhc0KlT_j7xjnRaVCbz1nnIzm4ZnJvACeWcaN8LaMhc2SOFPOos4ZGRthLE0cl4aF3uHDI7H3KXs35dM1-N33woSyyv5ObC5qN7fhH_kIIxG8R9He61HZlUV8GE9eL77HYYNUyLT26zRaETnwpz8xfFu-2h8jr7cZm7w93t2Luw0DsUW3u46lslwXUjOjXKZV4hMprTJOFNQprXiRYTSgjWalQsuNvrUpqLVCFlRJxnyKr70CV2XKaVAxOR1iPSpT1g5C0CpO0anoau6TFOPNWeiAp9lLGvZzn7WG51zcc-nZxupNbsKNzl0lO6183YI1X23CtXaB5ekmbBx2qfnbcDKeLcNGwzCglcwqslrU5osn85K8-bi7Q0eMoKiGjklSh8Ee1ecAZAiaSjf_NvvlHWkWiIQDNZrCUDLviR065u_A8WWQ9i6sV_ih-0DSwtPS6MSUOs1KX-rCFWGIjOOcFYzbCF70NMxtN9g87Nf4mjcJ9lTlSPE8UDxHikewPUAv2oEe_4Hb6tmRd2q9zP8KYQRPh8eokCHLYio_XyGMUKLx69QFMJKG0W8iySK417J6QIZxdHIVFxE873l_BoF_YPrgYkyfwAYqSv5-_-jgIVzHQ7ytdNuC9frHyj9Cn6ouHjfSSyC_ZG35A-ZHL_4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Disparities+in+uptake+of+BRCA1%2F2+genetic+testing+in+a+randomized+trial+of+telephone+counseling&rft.jtitle=Genetics+in+medicine&rft.au=Butrick%2C+Morgan&rft.au=Kelly%2C+Scott&rft.au=Peshkin%2C+Beth+N&rft.au=Luta%2C+George&rft.date=2015-06-01&rft.pub=Elsevier+Limited&rft.issn=1098-3600&rft.eissn=1530-0366&rft.volume=17&rft.issue=6&rft.spage=467&rft_id=info:doi/10.1038%2Fgim.2014.125&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=4265482571 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1098-3600&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1098-3600&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1098-3600&client=summon |